Krystal Biotech (KRYS) Prepaid Assets (2016 - 2026)
Krystal Biotech's (KRYS) quarterly Prepaid Assets came in at $16.0 million in Q1 2026, down 4.32% year-on-year from $16.8 million in Q1 2025, and up 7.52% quarter-over-quarter from $14.9 million in Q4 2025.
Krystal Biotech (KRYS) Prepaid Assets (2016 - 2026) Analysis & Trends
Krystal Biotech has disclosed Prepaid Assets across 11 years of filings, most recently posting $16.0 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $16.0 million, down 4.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (down 4.32% YoY), and the FY2025 annual result was $14.9 million, up 821.77% from the prior year.
- Prepaid Assets came in at $16.0 million for Q1 2026 at Krystal Biotech, up from $14.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $16.9 million in Q2 2025 to a low of $1.6 million in Q4 2024.
- The 5-year median for Prepaid Assets is $6.5 million (2023), against an average of $8.1 million.
- Across the five-year window, Prepaid Assets plunged 75.89% in 2024 and soared 821.77% in 2025, its largest moves.
- Krystal Biotech's Prepaid Assets stood at $4.6 million in 2022, then soared by 45.53% to $6.7 million in 2023, then slumped by 75.89% to $1.6 million in 2024, then jumped by 821.77% to $14.9 million in 2025, then increased by 7.52% to $16.0 million in 2026.
- The last three Prepaid Assets figures came in at $16.0 million (Q1 2026), $14.9 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Krystal Biotech | 10.23 Bn | 9.41 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.03 Mn |
| Dec 31, 2025 | 14.91 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Jun 30, 2025 | 16.88 Mn |
| Mar 31, 2025 | 16.75 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 8.96 Mn |
| Jun 30, 2024 | 7.75 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 6.49 Mn |
| Mar 31, 2023 | 5.04 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Jun 30, 2022 | 3.21 Mn |
| Mar 31, 2022 | 3.37 Mn |
| Dec 31, 2021 | 4.17 Mn |
| Sep 30, 2021 | 2.72 Mn |
| Jun 30, 2021 | 2.20 Mn |